What is Morgan Stanley's price target for MOR?

Morgan Stanley's latest stated price target for MorphoSys AG (MOR) is $10.40, from its action on Jan 16, 2024.

What is Morgan Stanley's rating on MOR?

Morgan Stanley rates MOR Equal-Weight, a neutral rating, as of Jan 16, 2024.

When did Morgan Stanley last change its view on MOR?

On Jan 16, 2024, Morgan Stanley downgrades to Equal-Weight from Overweight, price target $9.19 to $10.40.

Morgan Stanley MOR price target and rating history

Morgan Stanley rates MorphoSys AG (MOR) Equal-Weight with a $10.40 price target, as of its latest action on Jan 16, 2024. It has published 5 rating actions on MOR since January 2022, including 1 upgrade and 4 downgrades.

Current rating: Equal-Weight
Price target: $10.40
Median target, all firms: Too few
Actions on MOR: 5

Morgan Stanley price target on MOR

Morgan Stanley price target on MOR, each point a stated target, January 2022 to January 2024.

Every Morgan Stanley rating on MOR

Jan 16, 2024
DowngradeMorgan Stanley downgrades to Equal-Weight from Overweight, price target $9.19 to $10.40
Oct 13, 2023
UpgradeMorgan Stanley upgrades to Overweight from Underweight, price target $3.70 to $9.19
Jan 6, 2023
DowngradeMorgan Stanley downgrades to Underweight from Equal-Weight
Jan 14, 2022
DowngradeMorgan Stanley downgrades to Equal-Weight from Overweight, price target $22 to $14
Jan 14, 2022
DowngradeMorgan Stanley downgrades to Equal-Weight from Overweight

Questions about Morgan Stanley and MOR

What is Morgan Stanley's price target for MOR?: Morgan Stanley's latest stated price target for MorphoSys AG (MOR) is $10.40, from its action on Jan 16, 2024.
What is Morgan Stanley's rating on MOR?: Morgan Stanley rates MOR Equal-Weight, a neutral rating, as of Jan 16, 2024.
When did Morgan Stanley last change its view on MOR?: On Jan 16, 2024, Morgan Stanley downgrades to Equal-Weight from Overweight, price target $9.19 to $10.40.

More MOR rating histories

All Morgan Stanley ratings MOR news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.